tirzepatide weight loss study The SURMOUNT-MAINTAIN trial will help answer the question of what to do with the obesity medication dose to maintain long-term. The trial will evaluate whether reducing or continuing the Tirzepatide Weight Loss Injections in

The dose is 1000 mcg (1 mg)

However, the process becomes more challenging during a calorie deficit

El GLP-1 es una hormona que ayuda a regular los niveles de azcar en sangre y el apetito

Subcutaneous injection sites include the abdomen, upper arm, and thigh

Warnings and Precautions Not for type 1 diabetes or diabetic ketoacidosis Avoid in patients with history of medullary thyroid cancer or MEN 2 syndrome Caution in severe gastrointestinal disease or history of pancreatitis May delay absorption of oral medications Not recommended during pregnancy or breastfeeding Stay hydrated, especially during initial treatment Alternative Medications (by Indication) For type 2 diabetes or weight loss: Mounjaro (tirzepatide) dual GLP-1/GIP agonist Rybelsus (oral semaglutide) daily pill Trulicity (dulaglutide) weekly GLP-1 injection Victoza (liraglutide) daily GLP-1 injection Wegovy (semaglutide) higher-dose version for weight loss Metformin oral glucose control Insulin therapies for advanced cases Medication FAQs Ozempic (semaglutide) Is Ozempic insulin

Adjustments by patient type Patient demographics can influence how semaglutide is prescribed